New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
12:26 EDTZMHZimmer down slightly after FDA recalls PEEK Ardis Inserter
The FDA announced that it was issuing a Class I recall for Zimmer Spine's (ZMH) PEEK Ardis Inserter. A Class I recall is issued when the FDA believes that there is a reasonable probability that the use of a product could cause serious health problems. The device is used to insert Zimmer's PEEK Ardis Interbody Spacer during spinal surgery. Zimmer was told that the spacer has broken into fragments when too much lateral force is applied to the inserter in some cases, the FDA reported. As a result, patients may experience various adverse effects, including a tear in the thin covering of the spinal cord, cerebrospinal fluid leakage, significant blood loss and nerve injury, according to the agency. Long-term health risks may include disability, dysfunction, or death, it added. The FDA's recall was initiated on December 21. Zimmer, on December 20, had initiated a voluntary recall of all 315 of its PEEK inserter units. Zimmer said at that time that it had received reports of the spacer implant breaking, but did not list adverse health effects that could occur if the implant breaks. In early afternoon trading, Zimmer fell 38c, or 0.57%, to $66.35.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
16:56 EDTZMHKKR 2006 Fund reports 14.8% stake in Zimmer
Subscribe for More Information
16:39 EDTZMHLVB Acquisition Holding reports 14.8% stake in Zimmer
June 25, 2015
10:00 EDTZMHOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:32 EDTZMHZimmer downgraded to Hold from Buy at Brean Capital
Brean Capital downgraded Zimmer to Hold saying uncertainty over 2016 earnings potential following the Biomet acquisition is likely to linger for several quarters. Brean sees little room for multiple expansion pending greater clarity.
June 24, 2015
13:14 EDTZMHZimmer trading resumes, shares up 96c to $113.66
13:11 EDTZMHZimmer Biomet sees 2015 constant currency revenue growth 1.5%-2.0%
Subscribe for More Information
13:09 EDTZMHZimmer announces completion of Biomet acquisition
Subscribe for More Information
13:00 EDTZMHZimmer trading halted, pending news
Subscribe for More Information
11:54 EDTZMHSmith & Nephew to acquire Zimmer Unicondylar Knee system in U.S. market
Subscribe for More Information
11:32 EDTZMHZimmer required by FTC to divest assets as condition of Biomet acquisition
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use